摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-[(1-ethylpyrrolidin-2-yl)methyl]-2-hydroxy-5,6-dimethoxy-3-propylbenzamide

中文名称
——
中文别名
——
英文名称
N-[(1-ethylpyrrolidin-2-yl)methyl]-2-hydroxy-5,6-dimethoxy-3-propylbenzamide
英文别名
——
N-[(1-ethylpyrrolidin-2-yl)methyl]-2-hydroxy-5,6-dimethoxy-3-propylbenzamide化学式
CAS
——
化学式
C19H30N2O4
mdl
——
分子量
350.5
InChiKey
XGLIHZCJAFMECG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    25
  • 可旋转键数:
    8
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.63
  • 拓扑面积:
    71
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • [EN] A PROCESS FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE ALPHA-ASARONE FROM TOXIC BETA-ASARONE RICH ACORUS CALAMUS OIL<br/>[FR] PROCEDE DE PREPARATION DE ALPHA-ASARONE A ACTIVITE PHARMACOLOGIQUE A PARTIR D'UNE HUILE D'ACORE ODORANT RICHE EN BETA-ASARONE
    申请人:COUNCIL SCIENT IND RES
    公开号:WO2003082786A1
    公开(公告)日:2003-10-09
    The present invention relates to a process for the preparation of high purity and yield α-asarone, trans 2,4,5-trimethoxy cinnamaldehyde, 2,4,5-trimethoxy-phenyl propionone, from β-asarone or β-asarone rich Acorus calamus oil containing α and η-asarone by hydrogenating, followed by treatment with DDQ with or without solid support of silica gel or alumina in dry organic solvent and α-asarone can also be obtained by treating the hydrogenated product of β-asarone or β-asarone rich Acorus calamus with DDQ in an aqueous organic solvent to obtain an intermediate 2,4,5-trimethoxy phenyl propionone, which in turn is reduced with sodiumborohydride to obtain the corresponding 2,4,5-trimethoxy-phenyl propanol and followed by final treatment with a dehydrating agent.
    本发明涉及一种从含有α和η-芳香烃的β-芳香烃或β-芳香烃丰富的菖蒲油中通过加氢后用DDQ处理的高纯度和高产率α-芳香烃、顺式2,4,5-三甲氧基肉桂醛2,4,5-三甲氧基苯丙酮的制备方法,其中可以在干有机溶剂中使用硅胶或氧化铝固体载体,也可以通过在有机溶剂中处理β-芳香烃或β-芳香烃丰富的菖蒲油的加氢产物以获得中间体2,4,5-三甲氧基苯丙酮,然后用氢硼酸还原获得相应的2,4,5-三甲氧基苯丙醇,最后用脱剂进行最终处理以获得α-芳香烃
  • DDQ mediated one step dimerisation of beta-asarone or beta-asarone rich acorus calamus oil in the formation of novel neolignan
    申请人:Council of Scientific & Industrial Research
    公开号:US20030187306A1
    公开(公告)日:2003-10-02
    The present invention relates to a novel neolignan (NEOLASA-I) 3-ethyl-2-methyl-3-(2″,4″,5″-trimethoxy-phenyl-1-(2′,4′,5′-trimethoxy)phenyl-1-(2′,4′,5′-trimethoxy)phenyl-1-propene and a process for the preparation of high purity, higher yield neolignan, &agr;-asarone, 2,4,5-trimethoxy-phenyl propionone from &bgr;-asarone or &bgr;-asarone rich Acorus calamus oil containing &agr; and &ggr;-asarone by hydrogenating and dimerizing by treatment with DDQ in presence of an organic acid.
    本发明涉及一种新型新木酚类化合物(NEOLASA-I),即3-乙基-2-甲基-3-(2″,4″,5″-三甲氧基苯基)-1-(2′,4′,5′-三甲氧基苯基)-1-丙烯基-1-(2′,4′,5′-三甲氧基苯基)-1-丙烯基,以及从含有α-芳草醚和β-芳草醚的Acorus caLAmus油中通过氢化和二聚化处理并在有机酸存在下用DDQ制备高纯度、高产率的新木酚类化合物α-芳草醚、2,4,5-三甲氧基苯基丙酮的方法。
  • Process for the preparation of 1-Propyl-2, 4, 5-trimethoxybenzene from toxic beta-asarone of acorus calamus or from crude calamus oil containing beta-asarone
    申请人:COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
    公开号:US20020035299A1
    公开(公告)日:2002-03-21
    The invention relates to a process for the preparation of 1-Propyl-2, 4, 5-trimethoxybenzene useful as a aroma molecule and as a starting material and intermediate for preparation of various drugs. The process comprises providing crude calamus oil or &bgr;-asarone in a solvent; hydrogenating the solution in the presence of a catalyst; filtering the catalyst and removing the solvent under reduced pressure; subjecting the reduced calamus oil to column of silica gel chromatography using an eluent to obtain the desired product in liquid form with 85-97% purity.
    本发明涉及一种制备1-丙基-2,4,5-三甲氧基苯的方法,该方法可用作香气分子,也可用作各种药物的起始物和中间体。该方法包括提供粗马鞭草油或β-芹烯酮的溶剂;在催化剂存在下将溶液加氢;过滤催化剂并在减压下去除溶剂;将减少的马鞭草油经过硅胶色谱柱层析,使用洗脱剂以液体形式得到所需产品,纯度为85-97%。
  • Derivatives of N-(2-pyrrolidinylmethyl)-benzamide, process for their preparation, intermediates and a pharmaceutical preparation
    申请人:Astra Läkemedel Aktiebolag
    公开号:EP0156776A1
    公开(公告)日:1985-10-02
    Novel therapeutically active compounds of the formula wherein Z , being Z1, Z2 or Z3, is the same or different and selected among OH, OR', NH2, NR24, NHR', SH, SR4 and OR4 wherein R' is a formyl group, an acyl group, an alkoxycarbonyl group or a mono- or dialkylcarbamoyl group and R4 is a lower alkyl group, R2 is a hydrogen, a halogen, a lower alkyl or a lower trifluoroalkyl group, R3 is a hydrogen atom, a lower alkyl group, an alkenyl group, an alkynyl group or a phenyl group, which phenyl group could optionally be substituted by one or more of fluoro, chloro, bromo, trifluoromethyl, methyl, ethyl, methoxy or ethoxy in the ortho, meta or para positions, or optionally substituted by methylenedioxy, provided that at least one of Z1, Z2 and Z3 is a group OR4 and further provided that when Z2 is OH or NH2, Z' is NR24, NHR4, SH, SR4 or OR' or a physiologically acceptable salt or optical isomer thereof, intermediates and methods for their preparation, pharmaceutical preparations containing the compounds and methods for their therapeutical use.
    式中具有治疗活性的新型化合物 式中 Z,为 Z1、Z2 或 Z3,相同或不同,选自 OH、OR'、NH2、NR24、NHR'、SH、SR4 和 OR4 其中 R'为甲酰基、酰基、烷氧羰基或单烷基或二烷基基甲酰基,R4 为低级烷基、 R2 是氢、卤素、低级烷基或低级三氟烷基、 R3是氢原子、低级烷基、烯基、炔基或苯基,其中苯基可选择在正位、偏位或对位被、三甲基、甲基、乙基、甲氧基或乙氧基中的一个或多个取代,或可选择被亚甲基二氧基取代、条件是 Z1、Z2 和 Z3 中至少有一个是 OR4 基团,进一步条件是当 Z2 是 OH 或 NH2 时,Z'是 NR24、NHR4、SH、SR4 或 OR'或其生理上可接受的盐或光学异构体、中间体及其制备方法、含有这些化合物的药物制剂及其治疗使用方法。
  • Process for the preparation of 1-Propyl-2, 4, 5- trimethoxybenzene from toxic beta-asarone of Acorus calamus or from crude calamus oil containing beta-asarone
    申请人:COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH
    公开号:US20030113275A1
    公开(公告)日:2003-06-19
    The invention relates to a process for the preparation of 1-Propyl-2, 4, 5-trimethoxybenzene useful as a aroma molecule and as a starting material and intermediate for preparation of various drugs. The process comprises providing crude calamus oil or &bgr;-asarone in a solvent, hydrogenating the solution in the presence of a catalyst, filtering the catalyst and removing the solvent under reduced pressure, subjecting the reduced calamus oil to column of silica gel chromatography using an eluent to obtain the desired product in liquid form with 85-97% purity.
    本发明涉及一种制备 1-丙基-2,4,5-三甲氧基苯的工艺,可用作芳香分子和制备 各种药物的起始原料和中间体。该工艺包括在溶剂中提供粗菖蒲油或 &bgr;-asarone,在催化剂存在下对溶液进行氢化,过滤催化剂并在减压下除去溶剂,将还原后的菖蒲油用硅胶色谱柱进行洗脱,以获得所需的液态产品,纯度为 85-97%。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫